The use of a cyclosporin-ketoconazole combination: Making renal transplantation affordable in developing countries

European Journal of Clinical Pharmacology

Volumn 60, Issue 3, 2004, Pages 143-148

  Gerntholtz, T ^a   Pascoe, M D ^a   Botha, J F ^a   Halkett, J ^a   Kahn, D ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Cost savings; Cyclosporin; Ketoconazole

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; PREDNISONE;

ADOLESCENT; ADULT; CONTROLLED STUDY; COST CONTROL; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG COST; DRUG DOSE REDUCTION; ECONOMIC ASPECT; ETHNIC DIFFERENCE; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; REVIEW;

ADOLESCENT; ADULT; CYCLOSPORINE; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; GRAFT SURVIVAL; HUMANS; KETOCONAZOLE; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; SURVIVAL ANALYSIS; TIME FACTORS; TRANSAMINASES;

EID: 2942596319     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0745-0     Document Type: Review

References (13)

1. Odocha O, Kelly B, Trimble S, Murigande C, Toussaint RM, Callender CO (1996) Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy. Transplant Proc 28:907-909
2. Foradori A, Mezzano S, Videla C, Pefaur J, Elberg A (1998) Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of neoral and diltiazem or ketoconazole in stable adult kidney transplants. Transplant Proc 30:1685-1687
3. Sorenson AL, Lovdahl M, Hewitt JM, Granger DK, Almond PS, Russlie HQ et al (1994) Effects of ketoconazole on cyclosporine metabolism in renal allograft recipients. Transplant Proc 26:2822
4. First MR, Schroeder TJ, Michael A, Hariharan S, Weiskittel P, Wesley Alexander J (1993) Cyclosporine-ketoconazole interaction. Transplantation 55:1000-1004
5. Patton PR, Brunson ME, Pfaff WW, Howard RJ, Peterson JC, Ramos EL et al (1994) A preliminary report of diltiazem and ketoconazole. Transplantation 57:889-892
6. Watanabe T, Gao ZH, Shinozuka N, Schulick RD, Kuo A, Burdick JF (1997) Unexpectedly low immunocompetence in transplant patients on ketoconazole. (1997) Clin Transplant 11:599-603
7. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 341:1725-1730
8. NIH (1999) United States Renal Data System USRDS 1999 annual data report. National Institutes of Health, Bethesda, Md, pp 73-1112
9. Hariharan S, Schroeder TJ, First MR (1993) Effect of race on renal transplant outcome. Clin Transplant 7:235-239
10. Isaacs RB, Nock SL, Spencer CE (1999) Racial disparities in renal outcomes. Am J Kidney Dis 34:706-712
11. Rozon-Solomon M, Burrows L (1999) 'Tis better to receive than to give: the relative failure of the African-American community to provide organs for transplantation. Mt Sinai J Med 66:273-276
12. Ward FE, MacQueen JM (1996) Immunogenetic factors that may contribute to ethnic differences in renal allograft survival. Clin Transplant 10:620-624
13. Morris PJ, Johnson RJ, Fuggle SV, Belger MA, Briggs JD (1999) Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 354:1147-1152